• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

May 5, 2011: Risk Communication Advisory Committee Meeting Announcement

May 5, 2011
8:00 a.m. - 5:00 p.m.
Food and Drug Administration, 5630 Fishers Lane, Conference Room 1066, Rockville, MD 20857


On May 5, 2011, the Committee will hear and discuss developments in FDA's ongoing communications programs. The discussion will focus on the use of different channels for information dissemination, tracking how information is gathered and spread and thoughts on reaching less accessible target audiences. FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its Web site prior to the meeting, the background material will be posted on FDA's Web site after the meeting. Background material is available at http://www.fda.gov/AdvisoryCommittees/default.htmScroll down to the appropriate advisory committee link. 


Visitors attending the meeting must have a valid driver's license or other picture ID, in order to enter 5630 Fishers Lane. Please note visitors should park in the visitors parking lot in front of 5600 Fishers Lane, Rockville, MD 20857.


 Other Meeting Materials

Public Participation Information 

Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. 

  • Written submissions may be made to the contact person on or before April 29, 2011.  
  • Oral presentations from the public will be scheduled between approximately 1 p.m. and 2 p.m. on May 5, 2011. Those individuals interested in making formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentations on or before April 21, 2011. 

Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by April 22, 2011. 

Contact Information

  • Lee L. Zwanziger, Designated Federal Official
    10993 New Hampshire Avenue, Building 32, Room 3278
    Silver Spring, MD 20993
  • Phone 301-796-9151
  • FAX: 301-847-8611
    e-mail:  RCAC@fda.hhs.gov
  • FDA Advisory Committee Information Line
    301-443-0572 in the Washington, DC, area
    code 8732112560
    Please call the Information Line for up-to-date information on this meeting.

Persons attending FDA's advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact Lee L. Zwanziger at least 7 days in advance of the meeting. FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at  http://www.fda.gov/AdvisoryCommittees/default.htm for procedures on public conduct during advisory committee meetings.


Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2).